# A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00856193** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 33 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** NVA237

## Key facts

- **NCT ID:** NCT00856193
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856193, "A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00856193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*